期刊文献+

Turning point of organoid transplantation:first-in-human trial of iPSC-derived retinal organoid grafting in patients with retinitis pigmentosa

原文传递
导出
摘要 The discovery of induced pluripotent stem cells(iPSCs)has revolutionized the field of disease research,providing a promising platform for studying various conditions.Over the last decade,significant progress has been made in combining iPSCs with other cutting-edge technologies to investigate disease mechanisms and develop potential treatments.
出处 《Science China(Life Sciences)》 SCIE CAS CSCD 2024年第5期1082-1084,共3页 中国科学(生命科学英文版)
基金 partly supported by the National Science Fund for Distinguished Young Scholars(82125007)。
  • 相关文献

参考文献1

二级参考文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部